Growth Metrics

Bio Essence (BIOE) Cost of Revenue (2020 - 2025)

Bio Essence has reported Cost of Revenue over the past 6 years, most recently at $41040.0 for Q3 2025.

  • Quarterly results put Cost of Revenue at $41040.0 for Q3 2025, down 23.57% from a year ago — trailing twelve months through Dec 2025 was $132062.0 (up 14.96% YoY), and the annual figure for FY2025 was $30593.0, down 71.37%.
  • Cost of Revenue for Q3 2025 was $41040.0 at Bio Essence, down from $90479.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for BIOE hit a ceiling of $173299.0 in Q1 2023 and a floor of -$410559.0 in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $53698.0 (2024), compared with a mean of $55310.1.
  • Peak annual rise in Cost of Revenue hit 1532.74% in 2023, while the deepest fall reached 5603.47% in 2023.
  • Bio Essence's Cost of Revenue stood at $151315.0 in 2021, then plummeted by 95.07% to $7460.0 in 2022, then plummeted by 5603.47% to -$410559.0 in 2023, then soared by 109.9% to $40657.0 in 2024, then rose by 0.94% to $41040.0 in 2025.
  • The last three reported values for Cost of Revenue were $41040.0 (Q3 2025), $90479.0 (Q2 2025), and $543.0 (Q1 2025) per Business Quant data.